RT Journal Article
SR Electronic
T1 Evaluating targeted COVID-19 vaccination strategies with agent-based modeling
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.03.09.23285319
DO 10.1101/2023.03.09.23285319
A1 Hladish, Thomas J.
A1 Pillai, Alexander N.
A1 Pearson, Carl A. B.
A1 Toh, Kok Ben
A1 Tamayo, Andrea
A1 Stoltzfus, Arlin
A1 Longini, Ira M.
YR 2023
UL http://medrxiv.org/content/early/2023/03/10/2023.03.09.23285319.abstract
AB We evaluate approaches to vaccine distribution using an agent-based model of human activity and COVID-19 transmission calibrated to detailed trends in cases, hospitalizations, deaths, seroprevalence, and vaccine breakthrough infections in Florida, USA. We compare the incremental effectiveness for four different distribution strategies at four different levels of vaccine availability, reflecting different income settings’ historical COVID-19 vaccine distribution. Our analysis indicates that the best strategy to reduce severe outcomes is to actively target high disease-risk individuals. This was true in every scenario, although the advantage was greatest for the middle-income-country availability assumptions, and relatively modest compared to a simple mass vaccination approach for rapid, high levels of vaccine availability. Ring vaccination, while generally the most effective strategy for reducing infections, ultimately proved least effective at preventing deaths. We also consider using age group as a practical, surrogate measure for actual disease-risk targeting; this approach still outperforms both simple mass distribution and ring vaccination.We also find that the magnitude of strategy effectiveness depends on when assessment occurs (e.g., after delta vs. after omicron variants). However, these differences in absolute benefit for the strategies do not change the ranking of their performance at preventing severe outcomes across vaccine availability assumptions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported in part by The Emerson Collective, The Ron Conway Family, and NIH/NIAID (R56AI148284). Initial development of the agent based model was supported by the UFII COVID-19 SEED Fund. CABP was supported in part by the International Decision Support Initiative, which is funded by the Bill and Melinda Gates Foundation (OPP1202541), and by the World Health Organization (2022/1236532). The National Corporation Directory provided data on Florida businesses including their locations and NAICS categories. The authors acknowledge University of Florida Research Computing for providing computational resources and support that have contributed to the research results reported in this publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. All code used in the present study is available online at http://github.com/tjhladish/covid-abm and https://github.com/kokbent/synthpop-fl http://github.com/tjhladish/covid-abm